Paraplatin NovaPlus and Sodium phenylacetate and benzoate Intravenous
Determining the interaction of Paraplatin NovaPlus and Sodium phenylacetate and benzoate Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carboplatin
Brand name: Paraplatin, CARBOplatin Novaplus
Synonyms: Paraplatin
Generic Name: sodium benzoate / sodium phenylacetate
Brand name: Ammonul
Synonyms: Sodium Phenylacetate and Sodium Benzoate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Paraplatin NovaPlus-Sodium Phenylacetate and Sodium Benzoate
- Paraplatin NovaPlus-Sodium Phenylacetate and Sodium Benzoate Injection
- Paraplatin NovaPlus-Sodium phenylbutyrate
- Paraplatin NovaPlus-Sodium Phenylbutyrate Powder
- Paraplatin NovaPlus-Sodium Phenylbutyrate Tablets
- Paraplatin NovaPlus-Sodium phosphate dibasic and sodium phosphate monobasic
- Sodium phenylacetate and benzoate Intravenous-Parathyroid hormone
- Sodium phenylacetate and benzoate Intravenous-Parathyroid hormone Subcutaneous
- Sodium phenylacetate and benzoate Intravenous-Parcopa
- Sodium phenylacetate and benzoate Intravenous-Paregoric
- Sodium phenylacetate and benzoate Intravenous-Paremyd
- Sodium phenylacetate and benzoate Intravenous-Paremyd Ophthalmic